Giant Biogene Holding Co. Ltd., China’s largest provider of collagen-based skincare merchandise, has filed for a Hong Kong IPO, becoming a member of the rising listing of Chinese firms in search of to faucet into international capital by way of the monetary hub as they shrink back from more and more problematic U.S. listings.
The agency filed its prospectus to the Hong Kong Exchanges & Clearing Ltd. (HKEX) on Thursday, revealing that its income has grown for 3 consecutive years and elevated by virtually two thirds to 1.55 billion yuan ($232.5 million) in 2021 from 956.7 million yuan in 2019.
You’ve accessed an article obtainable solely to subscribers
VIEW OPTIONS
https://www.caixinglobal.com/2022-05-07/china-skincare-leader-giant-biogene-files-for-hong-kong-ipo-101881914.html
